Evidence map›Paper›PMID 41840099›Full record

ArticleScientific reports2026

R3MV: a novel reliable system architecture for skin cancer classification using progressive heterogeneous multiblock model.

S K Reshma, S R Reeja

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S K ReshmaDepartment of Computer Science and Engineering, VIT-AP University, Amaravathi, Andhra Pradesh, India.
S R ReejaDepartment of Computer Science and Engineering, VIT-AP University, Amaravathi, Andhra Pradesh, India. reeja.sr@vitap.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical picture categorization has been greatly enhanced by the use of deep learning, especially in the timely identification of skin lesions. Still, predictions from a single model remain unreliable due to their susceptibility to variations in the dataset, complicating their application to diverse clinical scenarios. This study introduces a unique CNN, PHMBCNN, designed to enhance classification accuracy using a progressive learning strategy. We propose the R3MV three-tier decision fusion system, which integrates predictions from (i) individual CNN model predictions, (ii) a feature fusion classification architecture, and (iii) a meta-classifier trained on the outputs of the CNN models. The final forecast is reached using a majority voting procedure, which enhances the reliability of the decision. The study utilizes two datasets for skin cancer: PAD_UFES_20 and HAM10000. Incorporating a GRU into the PHMBCNN model results in the PHMBCNN-GRU. The classification accuracy enhanced from 75.70% for the PAD_UFES_20 dataset to 80.69%, and from 92.07% for the HAM10000 dataset to 96.01%. The R3MV system design achieves 81.78% for PAD_UFES_20 and 99.3% for HAM10000.

Indexed as

Skin NeoplasmsClassification AlgorithmsConvolutional Neural NetworksDeep LearningHumansReproducibility of ResultsFeature fusion classifierGated recurrent unitMeta classifierProgressive hybrid multi block CNNReliable three level majority vote system architectureSkin malignancy

Identifiers

PMID41840099
PMCPMC13121763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.